We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Based Scoring of Lymphocytes Outperforms Traditional Pathologist Eyeballing

By LabMedica International staff writers
Posted on 22 Jul 2025

Melanoma is a type of skin cancer where tracking tumor-infiltrating lymphocytes plays a critical role in assessing the body’s immune response and predicting patient outcomes. More...

Traditionally, pathologists evaluate these immune cells visually under a microscope—a process known as "eyeballing" which is subjective and prone to variability. This lack of standardization can affect the accuracy of diagnoses and treatment decisions. As more tumor-infiltrating lymphocytes are linked with better patient outcomes, ensuring reliable assessments is crucial for guiding clinical care. Now, researchers have tested a new artificial intelligence (AI)-based method that provides a more consistent and reproducible approach to lymphocyte quantification, significantly outperforming conventional visual assessment.

In a study involving 45 institutions globally, researchers at Yale School of Medicine (New Haven, CT, USA) and Karolinska Institute (Stockholm, Sweden) led the development of an open-source AI tool designed to quantify tumor-infiltrating lymphocytes in melanoma tissue. The research team used a dataset of 60 melanoma samples, with 98 participants performing quantification. Of these, 40 were pathologists using traditional visual scoring, while 11 pathologists and 47 non-pathologist scientists used the AI tool. This open-source algorithm processes digitized pathology images and automates lymphocyte counting, reducing variability and offering a standardized method suitable for integration into clinical workflows.

In the study, published in JAMA Network Open, the AI tool showed superior reproducibility compared to traditional methods. The results confirm that AI-based quantification offers a robust, reliable alternative for assessing tumor-infiltrating lymphocytes. Although the retrospective design limits immediate clinical application, the publicly available dataset and algorithm provide a strong foundation for further validation. Researchers plan to continue refining the tool and integrating it into routine melanoma management, ultimately enhancing diagnostic accuracy and treatment personalization.

"Our findings suggest that an AI-driven lymphocyte quantification tool may provide consistent, reliable assessments with a strong potential for clinical use, offering a robust alternative to traditional methods," said Thazin Nwe Aung, PhD, lead author of the study.

Related Links:
Yale School of Medicine
Karolinska Institute


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Biochemical Analyzer
iBC 900
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.